Provided by Tiger Trade Technology Pte. Ltd.

GT Biopharma Inc.

6.68
+0.720012.08%
Post-market: 6.820.1413+2.12%19:56 EDT
Volume:43.38K
Turnover:268.76K
Market Cap:12.05M
PE:-0.51
High:6.68
Open:5.96
Low:5.83
Close:5.96
52wk High:28.75
52wk Low:4.91
Shares:1.80M
Float Shares:1.74M
Volume Ratio:1.24
T/O Rate:2.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.2195
EPS(LYR):-156.2099
ROE:-113.52%
ROA:-158.16%
PB:3.38
PE(LYR):-0.04

Loading ...

Apr 14, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 04, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Correspondence

Form CORRESP - Correspondence
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Feb 21, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 07, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 27, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 27, 2025

Major Issues Report

Form 8-K - Current report
Dec 23, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 28, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2024

Correspondence

Form CORRESP - Correspondence
Jun 27, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 26, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 07, 2024

Major Issues Report

Form 8-K - Current report